Teresa Esposito

Dr. Teresa Esposito

Institute of Genetics and Biophysics – ABT, Via Pietro Castellino 111 - 80131 Napoli, ITALY
+1
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2000 in Nature
Verified
Journal Article
Closed access
PDF file
ASA Smahi
A Smahi
GCGilles COURTOIS
Gilles COURTOIS
PVP Vabres
P Vabres
SYS Yamaoka
S Yamaoka
SHS Heuertz
S Heuertz
DND L Nelson
D L Nelson

1 December 2001 in The American Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SKS Kenwrick
S Kenwrick
HWH Woffendin
H Woffendin
TJT Jakins
T Jakins
SSS G Shuttleworth
S G Shuttleworth
EME Mayer
E Mayer
ICInternational IP Consortium
International IP Consortium
Incontinentia pigmenti (IP), or "Bloch-Sulzberger syndrome," is an X-linked dominant disorder characterized by abnormalities of skin, teeth, hair, and eyes; skewed X-inactivation; and recurrent miscarriages of male fetuses. IP results from mutations in the gene for NF-kappaB essential modulator (NEMO), with deletion of exons 4-10 of NEMO accounting for >80% of new mutations. Male fetuses inheriting this mutation and other "null" mutations of NEMO usually die in utero. Less deleterious mutations can result in survival of males subjects, but with ectodermal dysplasia and immunodeficiency. Male patients with skin, dental, and ocular abnormalities typical of those seen in female patients with IP (without immunodeficiency) are rare. We investigated four male patients with clinical hallmarks of IP. All four were found to carry the deletion normally associated with male lethality in utero. Survival in one patient is explained by a 47,XXY karyotype and skewed X inactivation. Three other patients possess a normal 46,XY karyotype. We demonstrate that these patients have both wild-type and deleted copies of the NEMO gene and are therefore mosaic for the common mutation. Therefore, the repeat-mediated rearrangement leading to the common deletion does not require meiotic division. Hypomorphic alleles, a 47,XXY karyotype, and somatic mosaicism therefore represent three mechanisms for survival of males carrying a NEMO mutation.

1 July 1996 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
MDM. D’eSposito
M. D’eSposito
NQN. A. Quaderi
N. A. Quaderi
Alfredo CiccodicolaAlfredo Ciccodicola
Alfredo Ciccodicola
PBP. Bruni
P. Bruni
TETeresa Esposito
Teresa Esposito
SBS. D. M. Brown
S. D. M. Brown

21 June 2021 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
AGAlessandro Gialluisi
Alessandro Gialluisi
MRMafalda Giovanna Reccia
Mafalda Giovanna Reccia
NMNicola Modugno
Nicola Modugno
TNTeresa Nutile
Teresa Nutile
ALAlessia Lombardi
Alessia Lombardi
TETeresa Esposito
Teresa Esposito
Background: Parkinson’s disease (PD) is a neurodegenerative movement disorder affecting 1–5% of the general population for which neither effective cure nor early diagnostic tools are available that could tackle the pathology in the early phase. Here we report a multi-stage procedure to identify candidate genes likely involved in the etiopathogenesis of PD. Methods: The study includes a discovery stage based on the analysis of whole exome data from 26 dominant late onset PD families, a validation analysis performed on 1542 independent PD patients and 706 controls from different cohorts and the assessment of polygenic variants load in the Italian cohort (394 unrelated patients and 203 controls). Results: Family-based approach identified 28 disrupting variants in 26 candidate genes for PD including PARK2, PINK1, DJ-1(PARK7), LRRK2, HTRA2, FBXO7, EIF4G1, DNAJC6, DNAJC13, SNCAIP, AIMP2, CHMP1A, GIPC1, HMOX2, HSPA8, IMMT, KIF21B, KIF24, MAN2C1, RHOT2, SLC25A39, SPTBN1, TMEM175, TOMM22, TVP23A and ZSCAN21. Sixteen of them have not been associated to PD before, were expressed in mesencephalon and were involved in pathways potentially deregulated in PD. Mutation analysis in independent cohorts disclosed a significant excess of highly deleterious variants in cases (p = 0.0001), supporting their role in PD. Moreover, we demonstrated that the co-inheritance of multiple rare variants (≥ 2) in the 26 genes may predict PD occurrence in about 20% of patients, both familial and sporadic cases, with high specificity (> 93%; p = 4.4 × 10− 5). Moreover, our data highlight the fact that the genetic landmarks of late onset PD does not systematically differ between sporadic and familial forms, especially in the case of small nuclear families and underline the importance of rare variants in the genetics of sporadic PD. Furthermore, patients carrying multiple rare variants showed higher risk of manifesting dyskinesia induced by levodopa treatment. Conclusions: Besides confirming the extreme genetic heterogeneity of PD, these data provide novel insights into the genetic of the disease and may be relevant for its prediction, diagnosis and treatment.

1 July 2010 in European Journal of Endocrinology
Verified
Journal Article
Closed access
DRDomenico Rendina
Domenico Rendina
FGFernando Gianfrancesco
Fernando Gianfrancesco
GFGianpaolo De Filippo
Gianpaolo De Filippo
Daniela MerlottiDaniela Merlotti
Daniela Merlotti
TETeresa Esposito
Teresa Esposito
LGLuigi Gennari
Luigi Gennari
Objective: FSH, via its receptor (FSHR), influences bone remodeling and osteoclast proliferation and activity. The aim of this study was to evaluate the influence of two single nucleotide polymorphisms (SNPs) of theFSHRgene on bone mineral density (BMD) and bone turnover markers (bone alkaline phosphatase and type I collagen C-telopeptides) in postmenopausal women.Methods: Two hundred and eighty-nine unrelated postmenopausal women were genotyped for the SNPs rs1394205 and rs6166. BMD was estimated using dual-energy X-ray absorptiometry and quantitative ultrasound (QUS) methodologies.Results: AA rs6166 women showed a lower BMD (femoral neck and total body), lower stiffness index (calcaneal QUS), and higher serum levels of bone turnover markers compared to GG rs6166 women. The prevalence of osteoporosis was significantly higher in AA rs6166 women compared with GG rs6166 women. These results were not influenced by circulating levels of FSH and estrogens.Conclusion: The SNP rs6166 of theFSHRgene significantly influences BMD in postmenopausal women. In particular, AA rs6166 women are at increased risk of postmenopausal osteoporosis compared with GG rs6166 women, independently of circulating levels of FSH and estrogens. Previous studies have demonstrated that this SNP influences cell and tissue response to hyperstimulation of FSHRin vivoandin vitro. Our study results appear in agreement with these experimental data and with known biological actions of FSH/FSHR system in bone homeostasis.

12 February 2000 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
Alfredo CiccodicolaAlfredo Ciccodicola
Alfredo Ciccodicola
MDM D'Esposito
M D'Esposito
TETeresa Esposito
Teresa Esposito
FGFernando Gianfrancesco
Fernando Gianfrancesco
CMC Migliaccio
C Migliaccio
MDM D'Urso
M D'Urso
Human sex chromosomes, which are morphologically and genetically different, share few regions of homology. Among them, only pseudoautosomal regions (PARs) pair and recombine during meiosis. To better address the complex biology of these regions, we sequenced the telomeric 400 kb of the long arm of the human X chromosome, including 330 kb of the human Xq/YqPAR and the telomere. Sequencing reveals subregions with distinctive regulatory and evolutionary features. The proximal 295 kb contains two genes inactivated on both the inactive X and Y chromosomes [SYBL1 and a novel homologue (HSPRY3) of Drosophilasprouty]. The GC-rich distal 35 kb, added in stages and much later in evolution, contains the X/Y expressed gene IL9R and a novel gene, CXYorf1, only 5 kb from the Xq telomere. These properties make Xq/YqPAR a model for studies of region-specific gene inactivation, telomere evolution, and involvement in sex-limited conditions.